|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|0.1 mM||21.01 mL||105.05 mL||210.1 mL|
|0.5 mM||4.2 mL||21.01 mL||42.02 mL|
|1 mM||2.1 mL||10.5 mL||21.01 mL|
|5 mM||0.42 mL||2.1 mL||4.2 mL|
*The above data is based on the productmolecular weight 475.97. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|MECHANISM OF ACTION||Inhibitor|
|Storage||at -20°C 3 years Powder|
Brivanib (BMS-540215) is a VEGFR -2 inhibitor with an IC50 of 25 nM and Ki of 26 nM.
BMS-690514 is a potent and selective inhibitor of epidermal growth factor receptor (EGFR), HER2, and HER4, as well as the VEGF receptor kina…
ZM323881 is a potent and selective inhibitor of human vascular endothelial growth factor receptor 2 (VEGFR-2/KDR) with IC50 value of 2 nM.
Imatinib (Gleevec) is a number of tyrosine kinase enzymes specific inhibitor.
Raf265 derivative is a derivative of Raf265 that is an oral, highly selective RAF and VEGFR kinase inhibitor with IC50 of of 5 to 10 μM.
SU 5416 is an inhibitor of vascular endothelial growth factor receptor (VEGFR) that also inhibits other tyrosine kinases KIT, MET, FLT3 and …
BIBF1120 (Vargatef) is a novel triple angiokinase inhibitor that inhibits three growth factor receptors simultaneously: VEGFR, PDGF and FGFR…